HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.

Rakovitch, E; Nofech-Mozes, S; Hanna, W; Narod, S; Thiruchelvam, D; Saskin, R; Spayne, J; Taylor, C; Paszat, L

Rakovitch, E; Nofech-Mozes, S; Hanna, W; Narod, S; Thiruchelvam, D; Saskin, R; Spayne, J; Taylor, C; Paszat, L.

Affiliation

Rakovitch E; Department of Radiation Oncology, University of Toronto, Toronto, Canada. eileen.rakovitch@sunnybrook.ca

Br J Cancer ; 106(6): 1160-5, 2012 Mar 13.

Article in En | MEDLINE | ID: mdl-22361634

Subject(s)

Biomarkers, Tumor/metabolism; Breast Neoplasms/metabolism; Carcinoma, Intraductal, Noninfiltrating/metabolism; Ki-67 Antigen/metabolism; Neoplasm Recurrence, Local; Receptor, ErbB-2/metabolism; Adult; Aged; Aged, 80 and over; Breast Neoplasms/mortality; Breast Neoplasms/pathology; Breast Neoplasms/surgery; Carcinoma, Intraductal, Noninfiltrating/mortality; Carcinoma, Intraductal, Noninfiltrating/pathology; Carcinoma, Intraductal, Noninfiltrating/surgery; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Mastectomy, Segmental; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Prognosis; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Carcinoma, Intraductal, Noninfiltrating / Receptor, ErbB-2 / Ki-67 Antigen / Neoplasm Recurrence, Local Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2012 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google